These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6642726)

  • 21. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
    Zhou MX; Chang TM
    Biomater Artif Cells Artif Organs; 1987; 15(3):549-58. PubMed ID: 3481554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide, and octanoic acid.
    Zeneroli ML; Ventura E; Baraldi M; Penne A; Messori E; Zieve L
    Hepatology; 1982; 2(5):532-8. PubMed ID: 7118066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
    Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA
    J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transference of hepatic coma to normal rats from galactosamine treated donors by reverse plasma exchange.
    Ryan CJ; Aslam M; Courtney JM
    Biomater Artif Cells Artif Organs; 1990; 18(4):477-82. PubMed ID: 2285809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
    Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U
    Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD; Hu MY; Amiot B; Rollins MD; Rao S; McGuire B; Bloomer JR; Hu WS; Cerra FB
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compressed spectral arrays of patients with fulminant hepatic failure in hepatic coma undergoing liver transplantation.
    Takeichi T; Asonuma K; Kim I; Inomata Y; Kasahara M; Ohwada S; Morishita Y; Tanaka K
    Clin Transplant; 2002 Aug; 16(4):273-9. PubMed ID: 12099983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport.
    Knudsen GM; Poulsen HE; Paulson OB
    J Hepatol; 1988 Apr; 6(2):187-92. PubMed ID: 3411098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.
    Shi ZQ; Chang TM
    Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667
    [No Abstract]   [Full Text] [Related]  

  • 31. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model.
    Arai K; Lee K; Berthiaume F; Tompkins RG; Yarmush ML
    Hepatology; 2001 Aug; 34(2):360-71. PubMed ID: 11481621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
    Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
    Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats.
    Reddy PV; Murthy ChR; Reddanna P
    Neurosci Lett; 2004 Sep; 368(1):15-20. PubMed ID: 15342125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Middle molecules in hepatic coma and uremia.
    Chang TM; Lister C
    Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086
    [No Abstract]   [Full Text] [Related]  

  • 35. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog.
    Nyberg SL; Cerra FB; Gruetter R
    Liver Transpl Surg; 1998 Mar; 4(2):158-65. PubMed ID: 9516569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats.
    Gove CD; Hughes RD; Ede RJ; Williams R
    Hepatology; 1997 Feb; 25(2):295-301. PubMed ID: 9021937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure.
    Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y
    Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of C-Phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats.
    Sathyasaikumar KV; Swapna I; Reddy PV; Murthy ChR; Roy KR; Dutta Gupta A; Senthilkumaran B; Reddanna P
    J Neurol Sci; 2007 Jan; 252(1):67-75. PubMed ID: 17169376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.
    Gove CD; Hughes RD; Williams R
    Br J Exp Pathol; 1982 Oct; 63(5):547-53. PubMed ID: 7171479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
    Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
    J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.